Skip to main content
Caplight Logo









Longevitix

Longevitix

Private
Tel AvivHealthcare & Life Scienceshttps://longevitix.co/

Last Round

Pre Seed

Feb 1, 2026

Company Overview

Longevitix operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Pre Seed round in February 2026.

Longevitix is a health technology company that provides an AI-powered clinical intelligence platform for longevity, preventive, and functional medicine practices.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Patient Engagement, Vertical SaaS, Data Integration

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Longevitix Comparables

Compare Longevitix with similar companies based on industry and business-model similarity.

Longevitix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Longevity AI
91%
Biolytica AG
82%
Reya Health Inc.
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Longevitix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 1, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Longevitix Investors

Notable investors and investment history

Longevitix investors
InvestorRounds
Fresh.FundPre Seed
Good CompanyPre Seed
Jibe VenturesPre Seed
Yachad Capital PartnersPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2026

    Grew 60% QoQ from 5 to 8 employees.

  • Apr 6, 2026

    Grew 75% QoQ from 4 to 7 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Longevitix Filings

Explore SEC and related filing metadata, where available.

Longevitix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Longevitix's valuation, stock price, and market status.

Is Longevitix a public or private company?

Longevitix is a private company.

What is the current stock price of Longevitix?

Longevitix is a private company, so its shares have no public market price. Caplight tracks Longevitix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Longevitix worth (valuation)?

Valuation information for Longevitix is not publicly available.

Can I buy Longevitix stock?

Longevitix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Longevitix's last funding round?

Longevitix's most recent funding round was Pre Seed on February 1, 2026.

Who are the main investors in Longevitix?

Key investors in Longevitix include Fresh.Fund, Good Company, Jibe Ventures, Yachad Capital Partners.

Will Longevitix IPO soon?

No public IPO plans have been announced for Longevitix.

How can I track Longevitix secondary market activity?

Caplight tracks bids, offers, and trades in Longevitix's shares on secondary markets.

Firmographic Details

HeadquartersTel Aviv
Employee Range10
Year Founded2025
Last FundingFeb 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?